{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:01:02Z","timestamp":1794747662307,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TI 07.001_005"],"award-info":[{"award-number":["TI 07.001_005"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001663","name":"Volkswagen Foundation","doi-asserted-by":"publisher","award":["9A888"],"award-info":[{"award-number":["9A888"]}],"id":[{"id":"10.13039\/501100001663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390874280"],"award-info":[{"award-number":["390874280"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["439226007"],"award-info":[{"award-number":["439226007"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["405772731"],"award-info":[{"award-number":["405772731"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["500627539"],"award-info":[{"award-number":["500627539"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["499292334"],"award-info":[{"award-number":["499292334"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["405772731"],"award-info":[{"award-number":["405772731"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["500627539"],"award-info":[{"award-number":["500627539"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["272983813"],"award-info":[{"award-number":["272983813"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["VirEOS2.0"],"award-info":[{"award-number":["VirEOS2.0"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hepatitis E virus (HEV) causes 3.3 million symptomatic cases and 44,000 deaths per year. Chronic infections can arise in immunocompromised individuals, and pregnant women may suffer from fulminant disease as a consequence of HEV infection. Despite these important implications for public health, no specific antiviral treatment has been approved to date. Here, we report combined functional, biochemical, and X-ray crystallographic studies that characterize the human antibody response in convalescent HEV patients. We identified a class of potent and broadly neutralizing human antibodies (bnAbs), targeting a quaternary epitope located at the tip of the HEV capsid protein pORF2\u00a0that\u00a0contains an N-glycosylation motif and is conserved across members of the <jats:italic>Hepeviridae<\/jats:italic>. These glycan-sensitive bnAbs specifically recognize the non-glycosylated pORF2 present in infectious particles but not the secreted glycosylated form acting as antibody decoy. Our most potent bnAb protects human liver-chimeric mice from intraperitoneal HEV challenge and co-housing exposure. These results provide insights into the bnAb response to this important emerging pathogen and support the development of glycan-sensitive antibodies to combat HEV infection.<\/jats:p>","DOI":"10.1038\/s41467-025-57182-1","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T15:46:21Z","timestamp":1740584781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5350-3371","authenticated-orcid":false,"given":"George","family":"Ssebyatika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0858-6124","authenticated-orcid":false,"given":"Katja","family":"Dinkelborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa J.","family":"Str\u00f6h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Hinte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Corneillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-8888","authenticated-orcid":false,"given":"Lucas","family":"Hueffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6956-3402","authenticated-orcid":false,"given":"Elina M.","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prossie L.","family":"Nankya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9788-7335","authenticated-orcid":false,"given":"Nina","family":"Pl\u00fcckebaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4932-1782","authenticated-orcid":false,"given":"Lukas","family":"Fehlau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Garn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Prallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-2894","authenticated-orcid":false,"given":"Ann-Kathrin","family":"Mehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9666-0753","authenticated-orcid":false,"given":"Anke R. M.","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Verhoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1418-1514","authenticated-orcid":false,"given":"Carina","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6395-4010","authenticated-orcid":false,"given":"Abel","family":"Viejo-Borbolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2293-3592","authenticated-orcid":false,"given":"Viet Loan","family":"Dao Thi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6789-4422","authenticated-orcid":false,"given":"Thomas","family":"Pietschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9468-7944","authenticated-orcid":false,"given":"Marc","family":"L\u00fctgehetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Meuleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0073-6689","authenticated-orcid":false,"given":"Maura","family":"Dandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-7241","authenticated-orcid":false,"given":"Thomas","family":"Krey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5750-4259","authenticated-orcid":false,"given":"Patrick","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"57182_CR1","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/liv.14468","volume":"40","author":"P Li","year":"2020","unstructured":"Li, P. et al. The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis. Liver Int. 40, 1516\u20131528 (2020).","journal-title":"Liver Int."},{"key":"57182_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.coviro.2014.01.006","volume":"4","author":"WH Van der Poel","year":"2014","unstructured":"Van der Poel, W. H. Food and environmental routes of Hepatitis E virus transmission. Curr. Opin. Virol. 4, 91\u201396 (2014).","journal-title":"Curr. Opin. Virol."},{"key":"57182_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.86","volume":"3","author":"N Kamar","year":"2017","unstructured":"Kamar, N. et al. Hepatitis E virus infection. Nat. Rev. Dis. Prim. 3, 17086 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"57182_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4254\/wjh.v3.i12.285","volume":"3","author":"EH Teshale","year":"2011","unstructured":"Teshale, E. H. & Hu, D. J. Hepatitis E: Epidemiology and prevention. World J. Hepatol. 3, 285\u2013291, (2011).","journal-title":"World J. Hepatol."},{"key":"57182_CR5","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.clinre.2016.01.005","volume":"40","author":"P Ingiliz","year":"2016","unstructured":"Ingiliz, P. et al. Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient. Clin. Res Hepatol. Gastroenterol. 40, e23\u2013e25 (2016).","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"key":"57182_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa0706992","volume":"358","author":"N Kamar","year":"2008","unstructured":"Kamar, N. et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 358, 811\u2013817 (2008).","journal-title":"N. Engl. J. Med"},{"key":"57182_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/cid\/ciw309","volume":"63","author":"S Pischke","year":"2016","unstructured":"Pischke, S. et al. Blood-borne Hepatitis E virus transmission: A relevant risk for immunosuppressed patients. Clin. Infect. Dis. 63, 569\u2013570 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"57182_CR8","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.jhep.2014.08.047","volume":"61","author":"P Behrendt","year":"2014","unstructured":"Behrendt, P., Steinmann, E., Manns, M. P. & Wedemeyer, H. The impact of hepatitis E in the liver transplant setting. J. Hepatol. 61, 1418\u20131429 (2014).","journal-title":"J. Hepatol."},{"key":"57182_CR9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/infdis\/jiz025","volume":"220","author":"A Andonov","year":"2019","unstructured":"Andonov, A. et al. Rat Hepatitis E virus linked to severe acute hepatitis in an immunocompetent patient. J. Infect. Dis. 220, 951\u2013955 (2019).","journal-title":"J. Infect. Dis."},{"key":"57182_CR10","doi-asserted-by":"publisher","unstructured":"Reuter, G., Boros, A. & Pankovics, P. Review of Hepatitis E Virus in Rats: Evident risk of species orthohepevirus C to human zoonotic infection and disease. Viruses 12, https:\/\/doi.org\/10.3390\/v12101148 (2020).","DOI":"10.3390\/v12101148"},{"key":"57182_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/hep.31138","volume":"73","author":"S Sridhar","year":"2021","unstructured":"Sridhar, S. et al. Transmission of Rat Hepatitis E Virus Infection to Humans in Hong Kong: A clinical and epidemiological analysis. Hepatology 73, 10\u201322 (2021).","journal-title":"Hepatology"},{"key":"57182_CR12","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/cid\/ciz953","volume":"71","author":"N Kamar","year":"2020","unstructured":"Kamar, N. et al. Ribavirin for Hepatitis E virus infection after organ transplantation: A large European retrospective multicenter study. Clin. Infect. Dis. 71, 1204\u20131211 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"57182_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","volume":"376","author":"FC Zhu","year":"2010","unstructured":"Zhu, F. C. et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376, 895\u2013902 (2010).","journal-title":"Lancet"},{"key":"57182_CR14","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1073\/pnas.1721345115","volume":"115","author":"X Yin","year":"2018","unstructured":"Yin, X. et al. Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection. Proc. Natl. Acad. Sci. USA 115, 4773\u20134778 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57182_CR15","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1099\/vir.0.066910-0","volume":"95","author":"S Nagashima","year":"2014","unstructured":"Nagashima, S. et al. Hepatitis E virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies. J. Gen. Virol. 95, 2166\u20132175 (2014).","journal-title":"J. Gen. Virol."},{"key":"57182_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15337-2","volume":"11","author":"VL Dao Thi","year":"2020","unstructured":"Dao Thi, V. L. et al. Stem cell-derived polarized hepatocytes. Nat. Commun. 11, 1677 (2020).","journal-title":"Nat. Commun."},{"key":"57182_CR17","doi-asserted-by":"publisher","first-page":"33175","DOI":"10.1074\/jbc.M110.106336","volume":"285","author":"L Xing","year":"2010","unstructured":"Xing, L. et al. Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J. Biol. Chem. 285, 33175\u201333183 (2010).","journal-title":"J. Biol. Chem."},{"key":"57182_CR18","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.1073\/pnas.0904848106","volume":"106","author":"TS Guu","year":"2009","unstructured":"Guu, T. S. et al. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc. Natl. Acad. Sci. USA 106, 12992\u201312997 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57182_CR19","doi-asserted-by":"publisher","first-page":"12986","DOI":"10.1073\/pnas.0903699106","volume":"106","author":"T Yamashita","year":"2009","unstructured":"Yamashita, T. et al. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc. Natl. Acad. Sci. USA 106, 12986\u201312991 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57182_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.2014296","volume":"14","author":"H Kaplon","year":"2022","unstructured":"Kaplon, H., Chenoweth, A., Crescioli, S. & Reichert, J. M. Antibodies to watch in 2022. MAbs 14, 2014296 (2022).","journal-title":"MAbs"},{"key":"57182_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJMoa2110275","volume":"386","author":"LL Hammitt","year":"2022","unstructured":"Hammitt, L. L. et al. Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N. Engl. J. Med. 386, 837\u2013846 (2022).","journal-title":"N. Engl. J. Med."},{"key":"57182_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/00006454-199809000-00007","volume":"17","author":"X Saez-Llorens","year":"1998","unstructured":"Saez-Llorens, X. et al. Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The MEDI-493 Study Group. Pediatr. Infect. Dis. J. 17, 787\u2013791 (1998).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"57182_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/00006454-199802000-00006","volume":"17","author":"KN Subramanian","year":"1998","unstructured":"Subramanian, K. N. et al. Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group. Pediatr. Infect. Dis. J. 17, 110\u2013115 (1998).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"57182_CR24","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","volume":"381","author":"S Mulangu","year":"2019","unstructured":"Mulangu, S. et al. A randomized, controlled trial of Ebola virus disease therapeutics. N. Engl. J. Med. 381, 2293\u20132303 (2019).","journal-title":"N. Engl. J. Med"},{"key":"57182_CR25","doi-asserted-by":"publisher","unstructured":"Focosi, D. et al. Monoclonal antibody therapies against SARS-CoV-2. Lancet Infect. Dis., https:\/\/doi.org\/10.1016\/S1473-3099(22)00311-5 (2022).","DOI":"10.1016\/S1473-3099(22)00311-5"},{"key":"57182_CR26","first-page":"604","volume":"25","author":"Y Gu","year":"2015","unstructured":"Gu, Y. et al. Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody. Nat. Publ. Group 25, 604\u2013620 (2015).","journal-title":"Nat. Publ. Group"},{"key":"57182_CR27","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.1073\/pnas.1101309108","volume":"108","author":"X Tang","year":"2011","unstructured":"Tang, X. et al. Structural basis for the neutralization and genotype specificity of hepatitis E virus. Proc. Natl. Acad. Sci. USA 108, 10266\u201310271 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57182_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42737-2","volume":"9","author":"M Ankavay","year":"2019","unstructured":"Ankavay, M. et al. New insights into the ORF2 capsid protein, a key player of the hepatitis E virus lifecycle. Sci. Rep. 9, 6243 (2019).","journal-title":"Sci. Rep."},{"key":"57182_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.739124","volume":"12","author":"Z Zhou","year":"2021","unstructured":"Zhou, Z., Xie, Y., Wu, C. & Nan, Y. The Hepatitis E virus open reading frame 2 protein: Beyond viral capsid. Front Microbiol 12, 739124 (2021).","journal-title":"Front Microbiol"},{"key":"57182_CR30","doi-asserted-by":"publisher","first-page":"19910","DOI":"10.1074\/jbc.M115.649764","volume":"290","author":"M Zhao","year":"2015","unstructured":"Zhao, M. et al. A comprehensive study of neutralizing antigenic sites on the Hepatitis E Virus (HEV) capsid by constructing, clustering, and characterizing a tool box. J. Biol. Chem. 290, 19910\u201319922 (2015).","journal-title":"J. Biol. Chem."},{"key":"57182_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17737-w","volume":"11","author":"GP Wen","year":"2020","unstructured":"Wen, G. P. et al. Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans. Nat. Commun. 11, 3971 (2020).","journal-title":"Nat. Commun."},{"key":"57182_CR32","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41591-019-0602-4","volume":"25","author":"SA Ehrhardt","year":"2019","unstructured":"Ehrhardt, S. A. et al. Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV. Nat. Med. 25, 1589\u20131600 (2019).","journal-title":"Nat. Med"},{"key":"57182_CR33","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.immuni.2021.12.003","volume":"55","author":"T Weber","year":"2022","unstructured":"Weber, T. et al. Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization. Immunity 55, 341\u2013354 e347 (2022).","journal-title":"Immunity"},{"key":"57182_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/protein\/gzr058","volume":"25","author":"AA Gilmartin","year":"2012","unstructured":"Gilmartin, A. A. et al. High-level secretion of recombinant monomeric murine and human single-chain Fv antibodies from Drosophila S2 cells. Protein Eng. Des. Sel. 25, 59\u201366 (2012).","journal-title":"Protein Eng. Des. Sel."},{"key":"57182_CR35","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1073\/pnas.1912307117","volume":"117","author":"D Todt","year":"2020","unstructured":"Todt, D. et al. Robust hepatitis E virus infection and transcriptional response in human hepatocytes. Proc. Natl Acad. Sci. USA 117, 1731\u20131741 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"57182_CR36","doi-asserted-by":"publisher","unstructured":"Hurt, A. C. & Wheatley, A. K. Neutralizing antibody therapeutics for COVID-19. Viruses 13, https:\/\/doi.org\/10.3390\/v13040628 (2021).","DOI":"10.3390\/v13040628"},{"key":"57182_CR37","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671\u2013675 (2022).","journal-title":"Nature"},{"key":"57182_CR38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1053\/j.gastro.2017.09.020","volume":"154","author":"C Montpellier","year":"2018","unstructured":"Montpellier, C. et al. Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein. Gastroenterology 154, 211\u2013223 e218 (2018).","journal-title":"Gastroenterology"},{"key":"57182_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/infdis\/jiw161","volume":"214","author":"P Behrendt","year":"2016","unstructured":"Behrendt, P. et al. Hepatitis E virus (HEV) ORF2 antigen levels differentiate between acute and chronic HEV infection. J. Infect. Dis. 214, 361\u2013368 (2016).","journal-title":"J. Infect. Dis."},{"key":"57182_CR40","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1053\/j.gastro.2017.10.041","volume":"154","author":"X Wu","year":"2018","unstructured":"Wu, X. et al. Pan-genotype Hepatitis E virus replication in stem cell\u2013derived hepatocellular systems. Gastroenterology 154, 663\u2013674.e667 (2018).","journal-title":"Gastroenterology"},{"key":"57182_CR41","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1099\/vir.0.034835-0","volume":"92","author":"TC Li","year":"2011","unstructured":"Li, T. C. et al. Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses. J. Gen. Virol. 92, 2830\u20132837 (2011).","journal-title":"J. Gen. Virol."},{"key":"57182_CR42","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jhep.2016.01.011","volume":"64","author":"L Allweiss","year":"2016","unstructured":"Allweiss, L. et al. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation. J. Hepatol. 64, 1033\u20131040 (2016).","journal-title":"J. Hepatol."},{"key":"57182_CR43","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/gutjnl-2015-311109","volume":"66","author":"IM Sayed","year":"2017","unstructured":"Sayed, I. M. et al. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Gut 66, 920\u2013929 (2017).","journal-title":"Gut"},{"key":"57182_CR44","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1128\/JVI.00114-16","volume":"90","author":"MD van de Garde","year":"2016","unstructured":"van de Garde, M. D. et al. Hepatitis E virus (HEV) genotype 3 infection of human liver chimeric mice as a model for chronic HEV infection. J. Virol. 90, 4394\u20134401 (2016).","journal-title":"J. Virol."},{"key":"57182_CR45","doi-asserted-by":"publisher","unstructured":"Lempp, F. A. et al. Potent broadly neutralizing antibody VIR-3434 controls Hepatitis B and D virus infection and reduces HBsAg in humanized mice. J. Hepatol, https:\/\/doi.org\/10.1016\/j.jhep.2023.07.003 (2023).","DOI":"10.1016\/j.jhep.2023.07.003"},{"key":"57182_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100646","volume":"5","author":"R Burm","year":"2023","unstructured":"Burm, R. et al. A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection. JHEP Rep. 5, 100646 (2023).","journal-title":"JHEP Rep."},{"key":"57182_CR47","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1002\/hep.22244","volume":"47","author":"T Vanwolleghem","year":"2008","unstructured":"Vanwolleghem, T. et al. Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain. Hepatology 47, 1846\u20131855 (2008).","journal-title":"Hepatology"},{"key":"57182_CR48","doi-asserted-by":"crossref","unstructured":"Das, A. et al. Cell entry and release of quasi-enveloped human Hepatitis viruses. Nat. Rev. Microbiol. 21, 573\u2013589 (2023).","DOI":"10.1038\/s41579-023-00889-z"},{"key":"57182_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00535-012-0682-0","volume":"48","author":"H Okamoto","year":"2013","unstructured":"Okamoto, H. Culture systems for hepatitis E virus. J. Gastroenterol. 48, 147\u2013158 (2013).","journal-title":"J. Gastroenterol."},{"key":"57182_CR50","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(23)02234-1","volume":"403","author":"S Huang","year":"2024","unstructured":"Huang, S. et al. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 403, 813\u2013823 (2024).","journal-title":"Lancet"},{"key":"57182_CR51","first-page":"a033472","volume":"9","author":"CM Walker","year":"2019","unstructured":"Walker, C. M. Adaptive immune responses in Hepatitis A virus and Hepatitis E virus infections. Csh Perspect. Med. 9, a033472 (2019).","journal-title":"Csh Perspect. Med"},{"key":"57182_CR52","doi-asserted-by":"publisher","first-page":"e1000762","DOI":"10.1371\/journal.ppat.1000762","volume":"6","author":"T Krey","year":"2010","unstructured":"Krey, T. et al. The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog. 6, e1000762 (2010).","journal-title":"PLoS Pathog."},{"key":"57182_CR53","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-1-4939-3043-2_17","volume":"1350","author":"M Backovic","year":"2016","unstructured":"Backovic, M. & Krey, T. Stable drosophila cell lines: An alternative approach to exogenous protein expression. Methods Mol. Biol. 1350, 349\u2013358 (2016).","journal-title":"Methods Mol. Biol."},{"key":"57182_CR54","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2144\/03353bm08","volume":"35","author":"T Iwaki","year":"2003","unstructured":"Iwaki, T., Figuera, M., Ploplis, V. A. & Castellino, F. J. Rapid selection of Drosophila S2 cells with the puromycin resistance gene. Biotechniques 35, 482\u2013484 (2003).","journal-title":"Biotechniques"},{"key":"57182_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr D. Biol. Crystallogr 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"57182_CR56","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1107\/S090744491003982X","volume":"67","author":"PR Evans","year":"2011","unstructured":"Evans, P. R. An introduction to data reduction: Space-group determination, scaling and intensity statistics. Acta Crystallogr D. Biol. Crystallogr 67, 282\u2013292 (2011).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"57182_CR57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D. Biol. Crystallogr 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"57182_CR58","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1107\/S0907444913022750","volume":"69","author":"G Bunkoczi","year":"2013","unstructured":"Bunkoczi, G. et al. Phaser.MRage: Automated molecular replacement. Acta Crystallogr D. Biol. Crystallogr 69, 2276\u20132286 (2013).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"57182_CR59","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"57182_CR60","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1107\/S0907444911056058","volume":"68","author":"OS Smart","year":"2012","unstructured":"Smart, O. S. et al. Exploiting structure similarity in refinement: Automated NCS and target-structure restraints in BUSTER. Acta Crystallogr D. Biol. Crystallogr 68, 368\u2013380 (2012).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"57182_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D. Biol. Crystallogr 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57182-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57182-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57182-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T16:23:12Z","timestamp":1740586992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57182-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57182"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57182-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"24 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.S., K.D., T.K., and P.B. are listed as inventors on a patent \u201cBROADLY NEUTRALIZING ANTIBODIES AGAINST HEPATITIS E VIRUS\u201d describing the use of glycan-sensitive antibodies p60.1 and p60.12 targeting HEV pORF2 for diagnostics, prevention and treatment of HEV infection (EP 22 162 453.9). These authors declare no restrictions on the publication of data and the remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1995"}}